CCL21 and ductal breast carcinoma in situ: The analysis confirms CCL21 on the surface of CD3+ T-lymphocytes (surface defined by CD3) in IDC with the CCL21 lymphocyte staining (Figure S7B) but not in DCIS (Figure S7A).